ÂÜÀòÂÒÂ×

The Scientific Development team at Genevant Sciences is responsible for advancing the company's nucleic acid drug development pipeline by leveraging cutting-edge lipid nanoparticle (LNP) technology and related delivery systems. This multidisciplinary team of scientists and engineers focuses on the innovation, optimization, and validation of new therapeutic candidates, collaborating closely with both internal and external partners to bring novel medicines from early discovery through to clinical development.